Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients

Cell Biochemistry and Function

Volumn 23, Issue 1, 2005, Pages 23-28

  Yilmaz, Hulya ^a   Isbir, Turgay ^a   Agachan, Bedia ^a   Karaali, Zeynep Ermis ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Taksim State Hospital   (Turkey)

Author keywords

CETP; Coronary artery disease; HDL cholesterol; Polymorphism; Turkish

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; EVALUATION STUDIES; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES; TURKEY;

EID: 11244318381     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1124     Document Type: Article

References (43)

1. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975; 1: 16-19.
2. Gordon TW, Castelli P, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-714.
3. Assman G, Schulte H, Eckardstein A, Huang Y. High density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124: S11-S20.
4. Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996; 124: S1-S9.
5. Stein O, Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 1999; 144: 285-301.
6. Mahley RW, Paloglu KH, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
7. Hergenc G, Schulte H, Assmann G, Von Eckardstein A. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis 1999; 145: 147-156.
8. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem 1995; 64: 235-257.
9. Navab M, Hama SY, Hough GP, et al. High density associated enzymes: their role in vascular biology. Curr Opin Lipidol 1998; 9: 449-456.
10. Morton RE. Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Curr Opin Lipidol 1999; 10: 321-327.
11. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990; 29: 1372-1376.
12. Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987; 327: 632-634.
13. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 1987; 15: 4698.
14. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989; 35: 49-56.
15. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high density lipoprotein and transfer protein activity. Clin Sci (Lond) 1990; 79: 575-581.
16. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994; 14: 336-344.
17. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-1671.
18. Kuivenhoven JA, de Knijff P, Boer JM, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997; 17: 560-568.
19. Song GJ, Han GH, Chae JJ, et al. The effects of the cholesterol ester transfer protein gene environmental factors on plasma high density lipoprotein cholesterol levels in the Korean population. Mol Cells 1997; 7: 615-619.
20. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 1998; 338: 86-93.
21. Gudnason V, Kakko S, Nicaud V, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999; 29: 116-128.
22. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000; 20: 1323-1329.
23. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110: 35-44.
24. Bruce C, Sharp DS, Tall AR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res 1998; 39: 1071-1078.
25. Gudnason V, Thormar K, Humphries SE. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and nonsmoking healthy men, and the effect on plasma HDL cholesterol and ApoA1 concentration. Clin Genet 1997; 51: 15-21.
26. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101: 1907-1912.
27. Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis 2000; 151: 509-518.
28. Mitchell RJ, Earl L, Williams J, Bisucci T, Gasiams H. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol 1994; 66: 13-25.
29. Tenkanen H, Koskinen P, Kontula K, et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 1991; 87: 574-578.
30. Miller SA, Dykes DD, Polesky HS. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
31. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350-1356.
32. McGowan MW, Artiss JD, Stranbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983; 29: 538-542.
33. Onaka LI. Lipids. In Clinical Chemistry Concepts and Applications, Anderson SC, Cockayne S (eds). Saunders: London, 1993.
34. Ross R. The pathogenesis of atherosclerosis. In Braunwald Heart Disease A Textbook of Cardiovascular Medicine (Vol 1, 4th edn) An HBJ International Edition, 1992; 1106-1124.
35. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985; 71: 881-888.
36. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
37. Isbir T, Yilmaz H, Agachan B, Karaali ZE. Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population. Clin Genet 2003; 64: 228-234.
38. Liu S, Schmitz C, Stampfer MJ, et al. A prospective study of Taq1B polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 2002; 161: 469-474.
39. Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V. The -629C > A polymorphism in the CETP gene does not explain the association of Taq1B polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 2001; 159: 187-192.
40. Wu JH, Lee YT, Hsu HC, Hsieh LL. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis 2001; 159: 451-458.
41. Goto A, Sasai K, Suzuki S, et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis 2001; 159: 153-163.
42. Meguro S, Takei I, Murata M, et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 2001; 156; 151-156.
43. Kawasaki I, Tahara H, Emoto M, Shoji T, Nishizawa Y. Relationship between Taq1B cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes 2002; 51: 871-874.